These observations indicate a direct role for PGC-1α in regulating lipid droplet formation in the RPE and suggest that the pharmacological activation of PGC-1α might be beneficial in reducing lipid and drusen formation in AMD patients. Here, PPARGC1A is linked to age-related macular degeneration.